.png)
Astremiha Therapeutics
Description
According to the WHO, infectious diseases are among the top three leading causes of death worldwide. ASTREMIHA Therapeutics is developing broad-spectrum antivirals aimed at blocking viral replication and strengthening the immune system to combat infections. These next-generation antivirals will address urgent and priority health needs such as AIDS and long COVID, with innovative preventive and curative properties.
